Bronchiolitis Obliterans Overview

Save information for later
Sign Up

Learn About Bronchiolitis Obliterans

What is the definition of Bronchiolitis Obliterans?
Bronchiolitis obliterans is an inflammatory condition that affects the lung's tiniest airways, the bronchioles. In affected people, the bronchioles may become damaged and inflamed leading to extensive scarring that blocks the airways. Symptoms of the condition include a dry cough; shortness of breath; and/or fatigue and wheezing in the absence of a cold or asthma. Many different chemicals (such as nitrogen oxides, ammonia, welding fumes or food flavoring fumes) and respiratory infections can cause lung injury that leads to Bronchiolitis obliterans. It can also be associated with rheumatoid arthritis and graft-versus-host disease following a lung or hematopoietic cell transplantation. Another similarly named disease, Bronchiolitis obliterans organizing pneumonia, is a different disease.
What are the alternative names for Bronchiolitis Obliterans?
  • Bronchiolitis obliterans
  • Obliterative bronchiolitis
Who are the top Bronchiolitis Obliterans Local Doctors?
Experienced in Bronchiolitis Obliterans
Dr. Juan A. Llompart
Pulmonary Medicine | Intensive Care Medicine
Experienced in Bronchiolitis Obliterans
Dr. Juan A. Llompart
Pulmonary Medicine | Intensive Care Medicine

Regional Employee Assistance Program Inc

605 E San Antonio St, 
Victoria, TX 
 (0.4 mi)
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Juan Llompart is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Victoria, Texas. Dr. Llompart and is rated as an Experienced provider by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are Asbestosis, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Gastrostomy, and Advanced Bronchoscopy. Dr. Llompart is currently accepting new patients.

Experienced in Bronchiolitis Obliterans
Dr. Robin E. Adams
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Experienced in Bronchiolitis Obliterans
Dr. Robin E. Adams
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

Citizens Medical Center County Of Victoria

2705 Hospital Dr, Suite 402, 
Victoria, TX 
 (1.7 mi)
361-582-5700
Languages Spoken:
English
See accepted insurances

Robin Adams is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Victoria, Texas. Dr. Adams and is rated as an Experienced provider by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pleural Effusion, Pneumonia, and Gastrostomy.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Bronchiolitis Obliterans
Dr. John A. Hartman
Family Medicine
Experienced in Bronchiolitis Obliterans
Dr. John A. Hartman
Family Medicine

Shea Physical Therapy Specialists LLC

5440 Everhart Rd, Suite 1, 
Corpus Christi, TX 
 (79.3 mi)
361-994-5224
Languages Spoken:
English
See accepted insurances

John Hartman is a Family Medicine provider in Corpus Christi, Texas. Dr. Hartman and is rated as an Experienced provider by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are Cirrhosis, Familial Combined Hyperlipidemia, Xanthoma, and Hypertension.

View All Doctors
What are the latest Bronchiolitis Obliterans Clinical Trials?
Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation (HSCT)- a Multicentre Phase II Trial
Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation (HSCT)- a Multicentre Phase II Trial
Who is this study for: Patients with Bronchiolitis Obliterans
Enrollment Status: Recruiting
Publish Date: February 19, 2025
Intervention Type: Drug
Study Drug: Nintedanib
Study Phase: Phase 2

Summary: This study investigates the safety and tolerability of Nintedanib in patients with bronchiolitis obliterans syndrome (BOS) following allogeneic hematopoietic cell transplantation. All study patients with BOS will be treated with the study drug Nintedanib (300 mg/day) as an add-on therapy to their basic immunosuppressive treatment over a 12-months treatment period.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment
Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment
Enrollment Status: Recruiting
Publish Date: February 18, 2025
Intervention Type: Device

Summary: This study is designed to measure the correlation of hyperpolarized 129-Xe magnetic resonance imaging (129-XeMRI) in allogeneic hematopoietic cell transplant (allo-HCT) recipients at MD Anderson Cancer Center (MDACC) who develop bronchiolitis obliterans syndrome (BOS) or BOS stage 0p (pulmonary impairment not meeting the definition for BOS, defined below) and controls with chronic graft-versus-hos...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center